Bridging the divide between efficacy and safety for time-to-event endpoint

Abstract available soon

About the speaker
Andrew Thomson

Andrew Thomson is a statistician at the EMA, in the Human Medicines Research & Development Support Division, where he supports products across the lifecycle. Prior to joining the EMA in 2014, he spent 7 years at the MHRA, initially as a Statistical Assessor in the Licensing Division, and subsequently as Head of Epidemiology in the Vigilance & Risk Management of Medicines Division.

Cookies help us deliver our services. By using our services, you agree to our use of cookies. Learn more